TER Tops Lam Research Stock on Price & Potential
TER is Lam Research’s peer in Semiconductor Materials & Equipment industry that has:
1) Lower valuation (P/OpInc) compared to Lam Research stock
2) But higher revenue and operating income growth
This disconnect between valuation and performance could mean that you are better off buying TER stock vs. LRCX stock
Key Metrics Compared
- What Cisco Stock Was Really Saying About AI
- Micron Stock And The Supply-Demand Tightrope
- The Catch Hiding In Eli Lilly Stock’s Growth Story
- How Nike’s Running Revival Changes The Nike Stock Story
- The Tariff Threat To Apple Stock Vanished. Its Replacement Is A Bigger Worry.
- What A Patient Investor Really Pays For Broadcom Stock
| Metric | LRCX | TER |
|---|---|---|
| P/OpInc* | 54.1x | 52.8x |
| LTM OpInc Growth | 40.5% | 70.1% |
| 3Y Avg OpInc Growth | 13.7% | 19.2% |
| LTM Revenue Growth | 26.5% | 30.3% |
| 3Y Avg Revenue Growth | 7.5% | 9.2% |
OpInc = Operating Income, P/OpInc = Price To Operating Income Ratio
But do these numbers tell the full story? Read Buy or Sell LRCX Stock to see if Lam Research still has an edge that holds up under the hood. As a quick background, Lam Research (LRCX) provides semiconductor processing equipment and services for integrated circuit fabrication to clients globally, including the United States, Asia, and Europe.
This is just one approach to evaluate investments. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure
Is The Mismatch In Stock Price Temporary
One way to check if Lam Research stock is expensive now versus the other tickers would be to see how these metrics compared across companies exactly a year ago. Specifically, if there has been a marked reversal in the trend for Lam Research in the last 12 months, then there is a chance that the current mismatch is likely to reverse. On the other hand, a persistent underperformance in revenue and operating income growth for Lam Research would reinforce the conclusion that the stock is expensive compared to its peers, but may not revert soon
Key Metrics Compared 1 Yr Prior
| Metric | LRCX | TER |
|---|---|---|
| P/OpInc* | 16.3x | 19.7x |
| LTM OpInc Growth | 44.7% | 24.7% |
| 3Y Avg OpInc Growth | 10.6% | -2.7% |
| LTM Revenue Growth | 26.8% | 13.1% |
| 3Y Avg Revenue Growth | 5.1% | 1.1% |
OpInc = Operating Income
Additional Metrics To Consider
| Metric | LRCX | TER |
|---|---|---|
| P/S | 18.5x | 14.4x |
| Market Cap (Current) | $ 402.2 Bil | $ 54.4 Bil |
| LTM Revenue | $ 21.68 Bil | $ 3.79 Bil |
| LTM Opinc | $ 7.43 Bil | $ 1.03 Bil |
| LTM Op Margin | 34.3% | 27.2% |
OpInc = Operating Income
Alternate buying based on valuation, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed its benchmark – a combination of the S&P 500, Russell, and S&P midcap index.